Intervention Protocol

Pramlintide for diabetes mellitus

  1. Diana Hortensia Barbonta1,*,
  2. Christopher William Loughlan2,
  3. JE Claire Dickerson3

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 17 FEB 2010

Assessed as up-to-date: 19 JAN 2010

DOI: 10.1002/14651858.CD008383

How to Cite

Barbonta DH, Loughlan CW, Dickerson JEC. Pramlintide for diabetes mellitus (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 2. Art. No.: CD008383. DOI: 10.1002/14651858.CD008383.

Author Information

  1. 1

    Emergency Hospital Alba, Endocrinology, Diabetes and Metabolic Disorders Department, Alba-Iulia, Transylvania, Romania

  2. 2

    Cambridge Institute for Research, Education and Management, Research, Cambridge, UK

  3. 3

    University of Hertfordshire, School of Education, Hatfield, Hertfordshire, UK

*Diana Hortensia Barbonta, Endocrinology, Diabetes and Metabolic Disorders Department, Emergency Hospital Alba, 23, 1989 Revolutiei Blvd., Alba-Iulia, Transylvania, 510053, Romania.

Publication History

  1. Publication Status: New
  2. Published Online: 17 FEB 2010




  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of pramlintide for diabetes mellitus.